Report: Global biosimilars market could reach $2.5B this year

05/7/2013 | Drug Store News

The global biosimilars market is forecast to expand to $2.5 billion this year, a growth of more than 20% from 2012, according to a report from U.K.-based firm Visiongain. The market could see rapid expansion through 2023 as biosimilar drugs enter the U.S. and European markets. Biosimilar versions of monoclonal antibodies and insulins will record the fastest growth, according to the report, which point to the potential product launches in Europe and the U.S. next year.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA